A comparison of isosorbide mononitrate, misoprostol and combination therapy for first trimester pre-operative cervical ripening

M. A. Ledingham, A. J. Thomson, C. B. Lunan, I. A. Greer, J. E. Norman

Research output: Contribution to journalArticle (Academic Journal)

Abstract

OBJECTIVE: To determine whether a combined therapy with isosorbide mononitrate (40mg) and misoprostol (400 microg) for pre-operative cervical ripening in the first trimester would result in improved clinical effectiveness, and fewer side effects compared with each agent used alone.DESIGN: Randomised controlled trial.SETTING: Glasgow Royal Infirmary.POPULATION: Sixty-six primigravid women scheduled for suction termination of pregnancy.METHODS: Women were randomly assigned to receive before surgery, per vaginam, isosorbide mononitrate 40 mg (n = 22), misoprostol 400 microg (n = 22) or both agents together [isosorbide mononitrate 40 mg and misoprostol 400 microg] (n = 22).MAIN OUTCOME MEASURES: 1. To assess the cumulative force required to dilate the cervix to 8 mm; 2. the onset of new symptoms before termination of pregnancy.RESULTS: The cervical resistance following combination therapy with isosorbide mononitrate and misoprostol was not significantly different than following misoprostol alone [24.5N vs 18.5N; median difference (95% CI) 19N (-22 to 49)]. Pre-treatment with misoprostol used alone resulted in a lower cervical resistance than isosorbide mononitrate alone (18.5N vs 39N, P = 0.04, Mann-Whitney U test). There was no difference in the number of women remaining asymptomatic following either isosorbide mononitrate or misoprostol or combination therapy [14/22 (64%) vs 11/21 (52%) vs 11/22 (50%), Fisher's exact test].CONCLUSIONS: We have not shown any advantage of combining misoprostol with the nitric oxide donor isosorbide mononitrate compared with misoprostol alone for pre-operative cervical ripening in the first trimester.
Original languageEnglish
Pages (from-to)276-280
Number of pages5
JournalBJOG: An International Journal of Obstetrics and Gynaecology
Volume108
Issue number3
Publication statusPublished - 2001

Bibliographical note

RIS file

Keywords

  • Abortifacient Agents, Nonsteroidal Abortion, Induced Adult Cervical Ripening Drug Therapy, Combination Female Humans Isosorbide Dinitrate Misoprostol Nitric Oxide Donors Pregnancy Treatment Outcome Vasodilator Agents

Fingerprint Dive into the research topics of 'A comparison of isosorbide mononitrate, misoprostol and combination therapy for first trimester pre-operative cervical ripening'. Together they form a unique fingerprint.

  • Cite this